179 related articles for article (PubMed ID: 22963934)
21. Prevalence of Multi-Drug Resistant Tuberculosis among Tuberculosis Patients Attending Chest Clinics in Osun-State, Nigeria.
Oyedeji GJ; Adeyemo C; Dissou A; Abiodun T; Alli OAT; Onaolapo OJ; Onaolapo AY; Adesiji Y; Olowe OA
Curr Pharm Biotechnol; 2020; 21(10):939-947. PubMed ID: 32101120
[TBL] [Abstract][Full Text] [Related]
22. Risk factors for multidrug resistant tuberculosis patients in Amhara National Regional State.
Mulu W; Mekonnen D; Yimer M; Admassu A; Abera B
Afr Health Sci; 2015 Jun; 15(2):368-77. PubMed ID: 26124781
[TBL] [Abstract][Full Text] [Related]
23. Risk factors for multidrug-resistant tuberculosis in Hong Kong.
Law WS; Yew WW; Chiu Leung C; Kam KM; Tam CM; Chan CK; Leung CC
Int J Tuberc Lung Dis; 2008 Sep; 12(9):1065-70. PubMed ID: 18713506
[TBL] [Abstract][Full Text] [Related]
24. Predictors of multidrug- and extensively drug-resistant tuberculosis in a high HIV prevalence community.
Andrews JR; Shah NS; Weissman D; Moll AP; Friedland G; Gandhi NR
PLoS One; 2010 Dec; 5(12):e15735. PubMed ID: 21209951
[TBL] [Abstract][Full Text] [Related]
25. Predictor of multidrug resistant tuberculosis in southwestern part of Ethiopia: a case control study.
Gobena D; Ameya G; Haile K; Abreha G; Worku Y; Debela T
Ann Clin Microbiol Antimicrob; 2018 Jul; 17(1):30. PubMed ID: 29970076
[TBL] [Abstract][Full Text] [Related]
26. Risk factors for multidrug-resistant tuberculosis in a tuberculosis unit in Madrid, Spain.
Suárez-García I; Rodríguez-Blanco A; Vidal-Pérez JL; García-Viejo MA; Jaras-Hernández MJ; López O; Noguerado-Asensio A
Eur J Clin Microbiol Infect Dis; 2009 Apr; 28(4):325-30. PubMed ID: 18830725
[TBL] [Abstract][Full Text] [Related]
27. Multidrug-resistant tuberculosis in Norway: a nationwide study, 1995-2014.
Jensenius M; Winje BA; Blomberg B; Mengshoel AT; Lippe Bv; Hannula R; Bruun JN; Knudsen PK; Rønning JO; Heldal E; Dyrhol-Riise AM
Int J Tuberc Lung Dis; 2016 Jun; 20(6):786-92. PubMed ID: 27155182
[TBL] [Abstract][Full Text] [Related]
28. Assessment of the risk factors associated with multidrug-resistant tuberculosis in Sudan: a case-control study.
Elduma AH; Mansournia MA; Foroushani AR; Ali HMH; Elegail AMA; Elsony A; Holakouie-Naieni K
Epidemiol Health; 2019; 41():e2019014. PubMed ID: 31010280
[TBL] [Abstract][Full Text] [Related]
29. Risk factors for mortality among patients diagnosed with multi-drug resistant tuberculosis in Uganda- a case-control study.
Kizito E; Musaazi J; Mutesasira K; Twinomugisha F; Namwanje H; Kiyemba T; Freitas Lopez DB; Nicholas NS; Nkolo A; Birabwa E; Dejene S; Zawedde-Muyanja S
BMC Infect Dis; 2021 Mar; 21(1):292. PubMed ID: 33752637
[TBL] [Abstract][Full Text] [Related]
30. Is HIV infection a risk factor for multi-drug resistant tuberculosis? A systematic review.
Suchindran S; Brouwer ES; Van Rie A
PLoS One; 2009; 4(5):e5561. PubMed ID: 19440304
[TBL] [Abstract][Full Text] [Related]
31. Multidrug-resistant Mycobacterium tuberculosis and associated risk factors in Oromia Region of Ethiopia.
Mulisa G; Workneh T; Hordofa N; Suaudi M; Abebe G; Jarso G
Int J Infect Dis; 2015 Oct; 39():57-61. PubMed ID: 26327121
[TBL] [Abstract][Full Text] [Related]
32. Multidrug resistant tuberculosis in Ethiopian settings and its association with previous history of anti-tuberculosis treatment: a systematic review and meta-analysis.
Eshetie S; Gizachew M; Dagnew M; Kumera G; Woldie H; Ambaw F; Tessema B; Moges F
BMC Infect Dis; 2017 Mar; 17(1):219. PubMed ID: 28320336
[TBL] [Abstract][Full Text] [Related]
33. HIV, multidrug-resistant TB and depressive symptoms: when three conditions collide.
Das M; Isaakidis P; Van den Bergh R; Kumar AM; Nagaraja SB; Valikayath A; Jha S; Jadhav B; Ladomirska J
Glob Health Action; 2014; 7():24912. PubMed ID: 25215909
[TBL] [Abstract][Full Text] [Related]
34. High risk of drug-resistant tuberculosis when first-line therapy fails in a high HIV prevalence setting.
Satti H; McLaughlin MM; Seung KJ; Becerra MC; Keshavjee S
Int J Tuberc Lung Dis; 2013 Jan; 17(1):100-6. PubMed ID: 23232009
[TBL] [Abstract][Full Text] [Related]
35. Risk factors and outcome of human immunodeficiency virus-infected patients with sporadic multidrug-resistant tuberculosis in New York City.
Mannheimer SB; Sepkowitz KA; Stoeckle M; Friedman CR; Hafner A; Riley LW
Int J Tuberc Lung Dis; 1997 Aug; 1(4):319-25. PubMed ID: 9432387
[TBL] [Abstract][Full Text] [Related]
36. Multidrug-resistant tuberculosis and risk factors associated with its development: a retrospective study.
Elmi OS; Hasan H; Abdullah S; Mat Jeab MZ; Bin Alwi Z; Naing NN
J Infect Dev Ctries; 2015 Oct; 9(10):1076-85. PubMed ID: 26517482
[TBL] [Abstract][Full Text] [Related]
37. Predictors of cure among HIV co-infected multidrug-resistant TB patients at Sizwe Tropical Disease Hospital Johannesburg, South Africa.
Umanah TA; Ncayiyana JR; Nyasulu PS
Trans R Soc Trop Med Hyg; 2015 May; 109(5):340-8. PubMed ID: 25787727
[TBL] [Abstract][Full Text] [Related]
38. Thyroid function in multidrug-resistant tuberculosis patients with or without human immunodeficiency virus (HIV) infection before commencement of MDR-TB drug regimen.
Ige OM; Akinlade KS; Rahamon SK; Edem VF; Arinola OG
Afr Health Sci; 2016 Jun; 16(2):596-602. PubMed ID: 27605977
[TBL] [Abstract][Full Text] [Related]
39. Predictors for multidrug-resistant tuberculosis among HIV-infected patients and response to specific drug regimens. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clinical Trials Group (ACTG), National Institutes for Health.
Telzak EE; Chirgwin KD; Nelson ET; Matts JP; Sepkowitz KA; Benson CA; Perlman DC; El-Sadr WM
Int J Tuberc Lung Dis; 1999 Apr; 3(4):337-43. PubMed ID: 10206505
[TBL] [Abstract][Full Text] [Related]
40. Risk factors for multidrug-resistant tuberculosis among tuberculosis patients in Serbia: a case-control study.
Stosic M; Vukovic D; Babic D; Antonijevic G; Foley KL; Vujcic I; Grujicic SS
BMC Public Health; 2018 Sep; 18(1):1114. PubMed ID: 30208864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
